how long are most people on glp 1 GLP-1 Survey: 37.5% of Stop GLP-1s after Just 3 Months Anti Obesity Med GLP1

Nausea is a side effect which affects 3050% of patients taking GLP-1R agonists at clinically licensed doses 15 , with higher doses glycemically more effective but consistently associated with unacceptable tolerability 16,17,18,19

see Methods for details)

Traditional Therapeutic Targets Related to Obesity GDF8 GDF8 (Growth Differentiation Factor 8), commonly known as Myostatin (MSTN), is a protein predominantly expressed by skeletal muscle cells and is a member of the TGF- (Transforming Growth Factor-) superfamily

[19] [20] Whilst some evidence supports probiotic use for specific conditionssuch as antibiotic-associated diarrhoea or certain types of irritable bowel syndromethe quality and strength of evidence varies considerably between different strains and formulations